Kodiak Sciences Inc KOD

NAS: KOD | ISIN: US50015M1099   17:26
3,350 USD (+4,36%)
(+4,36%)   17:26
Grafiek Kodiak Sciences Inc Grafiek Kodiak Sciences Inc

Kodiak Sciences Inc in het nieuws

28 maart 2024 · Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results · Persbericht

26 maart 2024 · Kodiak Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results and Host Business Updates Webcast on March 28, 2024 · Persbericht

30 januari 2024 · Kodiak Sciences Announces Upcoming Presentation of First Time Results of KSI-501ABC Phase 1 Study at the Angiogenesis, Exudation, and Degeneration 2024 Virtual Meeting · Persbericht

4 januari 2024 · Kodiak Sciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference · Persbericht

6 november 2023 · Kodiak reboots tarcocimab tedromer development program following strong positive results in Phase 3 diabetic retinopathy GLOW study and following dialogue with US regulatory authorities on a regulatory pathway for BLA submission · Persbericht

2 november 2023 · Kodiak Sciences Announces First Time Presentation Of Primary Endpoint Data From Tarcocimab Tedromer Phase 3 Glow Study In Patients With Diabetic Retinopathy At American Academy Of Ophthalmology Annual Meeting · Persbericht

11 oktober 2023 · Kodiak Sciences Announces Upcoming Presentations at the 56th Annual Scientific Meeting of the Retina Society · Persbericht

8 september 2023 · Kodiak Sciences to Present at the Morgan Stanley 21st Annual Global Healthcare Conference · Persbericht

7 september 2023 · New one-year results for Kodiak's tarcocimab tedromer in the pivotal BEACON trial reinforce durability signal and demonstrate matched efficacy and comparable safety and tolerability in retinal vein occlusion · Persbericht

14 augustus 2023 · Kodiak Sciences Announces Second Quarter 2023 Financial Results and Recent Business Highlights · Persbericht

Profiel Kodiak Sciences Inc

Biotechnologie
Gezondheidstechnologie
Productie
Productie van biologische producten

Werknemers: 101

Aandelen Kodiak Sciences Inc

Beurswaarde: 168,60 miljoen USD

Effecten: 52,52 miljoen

Beta: 2,23

Mijn selecties